Ernest Hendrix MD in Athens, Alabama

Medical School: University Of South Alabama College Of Medicine
Graduation Year: 1991
The Primary Medical Specialty for Ernest Hendrix MD is listed as: Family Practice
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 4981643657
NPI #: 1831182567
NPI Created On: 08/29/2005
NPI Last Updated Listed as: 02/13/2020
Primary Taxonomy Code: 207Q00000X
License Number:
16454
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Vaccine for influenza for injection into muscle
2. Vaccine for influenza for administration into muscle, 0.5 ml dosage
3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
4. Established patient office or other outpatient visit, typically 5 minutes
5. Established patient office or other outpatient visit, typically 15 minutes
6. Established patient office or other outpatient, visit typically 25 minutes
7. Initial hospital inpatient care, typically 70 minutes per day
8. Subsequent hospital inpatient care, typically 25 minutes per day
9. Hospital discharge day management, 30 minutes or less
10. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
11. Administration of influenza virus vaccine
12. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
13. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
14. Injection, methylprednisolone acetate, 20 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.